Long-term outcomes of older patients with relapsed/refractory NHL referred to ASCT

Abstract

We conclude that the benefit of ASCT in older patients with R/R NHL was not overestimated in previous studies, though most of them focused only on those actually transplanted. Our results also show that the benefit in these patients is durable.

Patients with poor PS at relapse had high salvage-related mortality and only minority of them proceeded to ASCT, however, their numbers are too small to justify strong conclusions. Comorbidity score did not affect treatment results.

Keywords

• stem-cell transplantation
• elderly-patients
• lymphoma
• chemotherapy
• hodgkin